Detailed Information on Publication Record
2011
Imbalance in T-cell and cytokine profiles in patients with relapsing-remitting multiple sclerosis
MIKULKOVÁ, Zuzana, Petra PRAKSOVÁ, Pavel ŠTOURAČ, Josef BEDNAŘÍK, Jaroslav MICHÁLEK et. al.Basic information
Original name
Imbalance in T-cell and cytokine profiles in patients with relapsing-remitting multiple sclerosis
Authors
MIKULKOVÁ, Zuzana (203 Czech Republic, belonging to the institution), Petra PRAKSOVÁ (203 Czech Republic), Pavel ŠTOURAČ (203 Czech Republic), Josef BEDNAŘÍK (203 Czech Republic) and Jaroslav MICHÁLEK (203 Czech Republic, guarantor, belonging to the institution)
Edition
Journal of the neurological sciences, Netherlands, Amsterdam : Elsevier, 2011, 0022-510X
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30000 3. Medical and Health Sciences
Country of publisher
Netherlands
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 2.353
RIV identification code
RIV/00216224:14740/11:00051674
Organization unit
Central European Institute of Technology
UT WoS
000286850900025
Keywords (in Czech)
roztroušená skleróza; T lymfocyty; paměťové buňky; cytokiny; průtoková cytometrie
Keywords in English
multiple sclerosis; T-cells; memory cells; cytokines; flow cytometry
Tags
International impact, Reviewed
Změněno: 1/4/2012 14:19, Olga Křížová
Abstract
V originále
In the present study, T-lymphocyte populations and pro-inflammatory as well as suppressive cytokine profiles were evaluated in detail in previously untreated patients with relapsing-remitting multiple sclerosis (RRMS). CD4(+) and CD8(+) naive, central memory (Tcm), effector memory (Tem), terminal effector memory (Ttem), CD4(+) regulatory T-cells (Treg) and CD8(+) T-suppressor cells (Ts) were analysed using flow cytometry, and levels of ten plasma cytokines were determined using fluorescent bead-based immunoassay. We evaluated two groups of RRMS with minor (n=33) and major (n=25) clinical impairment and compared them with healthy controls (n=40) in order to detect any correlation between severity of MS clinical symptoms and immune disturbances. In conclusion, we demonstrate complex immune dysbalances in untreated MS patients.
Links
MSM0021622404, plan (intention) |
|